{
    "2021-05-10": [
        [
            {
                "time": "2021-05-10",
                "original_text": "How This FDA Move Could Push Pfizer Stock Deeper Into A Winning Spree",
                "features": {
                    "keywords": [
                        "FDA",
                        "Pfizer",
                        "stock",
                        "winning spree"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false"
                }
            },
            {
                "time": "2021-05-10",
                "original_text": "The U.S. will begin giving COVID-19 shots to 12- to 15-year-olds as Pfizer’s vaccine gets expanded authorization",
                "features": {
                    "keywords": [
                        "U.S.",
                        "COVID-19",
                        "Pfizer",
                        "expanded authorization"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false"
                }
            },
            {
                "time": "2021-05-10",
                "original_text": "FDA authorizes emergency use of Pfizer, BioNTech COVID vaccine to kids 12-15",
                "features": {
                    "keywords": [
                        "FDA",
                        "emergency use",
                        "Pfizer",
                        "BioNTech",
                        "kids"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false"
                }
            },
            {
                "time": "2021-05-10",
                "original_text": "Dow Jones Rallies 300 Points To Extend Win Streak; Nasdaq Drops As Tech Stocks Weigh",
                "features": {
                    "keywords": [
                        "Dow Jones",
                        "rallies",
                        "Nasdaq",
                        "drops",
                        "tech stocks"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "finance",
                        "technology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-05-10",
                "original_text": "BioNTech’s Covid-19 Vaccine Success Sparks Investments in German Biotech",
                "features": {
                    "keywords": [
                        "BioNTech",
                        "vaccine",
                        "success",
                        "investments",
                        "German biotech"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false"
                }
            },
            {
                "time": "2021-05-10",
                "original_text": "EU won’t renew AstraZeneca COVID-19 vaccine; Pfizer shot will take precedence",
                "features": {
                    "keywords": [
                        "EU",
                        "AstraZeneca",
                        "Pfizer",
                        "precedence"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false"
                }
            },
            {
                "time": "2021-05-10",
                "original_text": "BioNTech Delivers Blowout Q1 Results",
                "features": {
                    "keywords": [
                        "BioNTech",
                        "Q1 results",
                        "blowout"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-05-10",
                "original_text": "BioNTech committed to deliver 1.8 bln doses of COVID-19 vaccine this year",
                "features": {
                    "keywords": [
                        "BioNTech",
                        "committed",
                        "doses",
                        "vaccine"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-05-10",
                "original_text": "BioNTech Rises on Revenue Jump Due to Sale of COVID Vaccine",
                "features": {
                    "keywords": [
                        "BioNTech",
                        "revenue jump",
                        "COVID vaccine"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}